Purchase Order 75N95021P00044
- Not listed
- This is a firm fixed-price federal purchase order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.), a for-profit manufacturer of medical imaging products and services. The $18,844.80 contract is for the provision of an ULTRAVIEW620013 laser system, serial number 02UV035, with no set-aside designation. Revvity Health Sciences is a subsidiary of the...
- This purchase order for $282,527.04 was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Revvity Health Sciences, Inc. for the maintenance of five PerkinElmer Operetta and Opera Phenix laboratory instruments located in Potomac, Maryland. The non-competitive solicitation sought renewal of an annual maintenance agreement for the instruments, requiring comprehensive maintenance, calibration, and repair...
- This is a $307,314.92 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for the provision of lab equipment. The award does not contain a set-aside designation. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity Inc., which provides medical imaging products and...
- This is a $696,235.12 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract is for preventative maintenance and repair services on specialized scientific instrumentation used for biological research, including one Operetta CLS system, six Opera Phenix systems, one Flex 750 plate handler, and one...
- The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $3.86 million firm fixed price purchase order to Molecular Devices LLC for the acquisition of five Molecular Devices ImageXpress Confocal High-Content Imaging Systems, one FLIPR Penta high-throughput cellular screening system, along with associated software, services, consumables, installation, training, customization, maintenance, and technical support. The products and services are to support the...
- This firm fixed price purchase order for $350,841.84 was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, to provide maintenance agreements covering multiple units of high throughput microplate-based automated imaging systems. Specifically, the contract calls for gold service plans with preventative maintenance visits for...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.), for the procurement of laboratory equipment. The contract has a total ceiling value of $37,186.89 and a period of performance through April 29, 2016. No small business set-aside was used for this award. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity Inc., which provides a range of...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $257,419.60 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the supply of a ViewLux HTS Imager from PerkinElmer Health Sciences Inc. This equipment will be used by the National Center for Advancing Translational Sciences (NCATS) to support its liquid dispensing high-throughput assays. The contract does not have a set-aside designation. Revvity Health Sciences,...
- The U.S. National Center for Advancing Translational Sciences (NCATS) awarded a $62,000 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the delivery of COVID-19 high throughput homogeneous assays for the detection of SARS-CoV-2 proteins in 384-well plates. This award, which did not utilize a set-aside, was made on April 15, 2020 with a completion date of October 31, 2020 under the Coronavirus COVID-19 national interest action. Revvity Health Sciences, Inc. is a subsidiary of...
- The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order to Revvity Health Sciences, Inc. for annual preventative maintenance services on its existing Operetta CLS' and Opera Phenix automated imaging systems. The $530,109.36 contract has a period of performance from April 26, 2024 to April 25, 2025. This is a non-competitive, commercial services acquisition...
This firm fixed price purchase order was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Revvity Health Sciences, Inc. for $1,276,403.77. The contract calls for the delivery of an Opera Phenix High Content Screening Imager and associated parts from manufacturer PerkinElmer. This equipment will be used by NCATS' Emerging Technologies Branch BSL3 Laboratory to screen potential drugs against SARS-CoV-2, the virus that causes COVID-19, in human lung cells. The imager and its technical capabilities are consistent with those outlined in the earlier solicitation notice seeking responses from small businesses. Funding for this coronavirus-related acquisition is being provided by the Department of Health and Human Services to support NCATS' translational sciences research mission.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Opera Phenix High Content Screening Imager or Brand Equal for NCATS ETB BSL3 Laboratory | 75N95021Q00011 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Pre-Solicitation 1/2 | 11/9/20, 6:05 PM | |
Opera Phenix High Content Screening Imager for NCATS ETB BSL3 Laboratory | 75N95021Q00011 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Limited / Sole Source Justification 2/2 | 1/4/21, 5:50 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3m | 12/18/20 |